FAS, Fas cell surface death receptor, 355

N. diseases: 754; N. variants: 47
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0000737
Disease: Abdominal Pain
Abdominal Pain
0.100 Biomarker phenotype HPO
CUI: C2132198
Disease: Abnormal blistering of the skin
Abnormal blistering of the skin
0.100 Biomarker phenotype HPO
CUI: C4011556
Disease: Abnormal eyebrow morphology
Abnormal eyebrow morphology
0.100 Biomarker group HPO
CUI: C2675111
Disease: Abnormal eyelash morphology
Abnormal eyelash morphology
0.100 Biomarker phenotype HPO
CUI: C4025758
Disease: Abnormal myocardium morphology
Abnormal myocardium morphology
0.100 Biomarker phenotype HPO
CUI: C4531156
Disease: Abnormal proportion of CD4 T cells
Abnormal proportion of CD4 T cells
0.100 Biomarker phenotype HPO
CUI: C4531155
Disease: Abnormal proportion of CD8 T cells
Abnormal proportion of CD8 T cells
0.100 Biomarker phenotype HPO
CUI: C4280772
Disease: Abnormal serum interleukin level
Abnormal serum interleukin level
0.100 Biomarker phenotype HPO
CUI: C4021032
Disease: Abnormal vitamin B12 level
Abnormal vitamin B12 level
0.100 Biomarker phenotype HPO
CUI: C0702166
Disease: Acne
Acne
0.100 Biomarker disease HPO
CUI: C0001175
Disease: Acquired Immunodeficiency Syndrome
Acquired Immunodeficiency Syndrome
0.020 GeneticVariation group LHGDN Genomic analysis of Fas and FasL genes and absence of correlation with disease progression in AIDS. 15042330 2004
CUI: C0001175
Disease: Acquired Immunodeficiency Syndrome
Acquired Immunodeficiency Syndrome
0.020 Biomarker group BEFREE These data suggest an involvement of the CD95 receptor/ligand system in T-cell depletion and apoptosis in AIDS and may open new avenues of rational intervention strategies. 8781430 1996
CUI: C0001306
Disease: Acute alcoholic liver disease
Acute alcoholic liver disease
0.200 Therapeutic disease RGD Dihydroartemisinin protects against alcoholic liver injury through alleviating hepatocyte steatosis in a farnesoid X receptor-dependent manner. 27939985 2017
CUI: C0742343
Disease: Acute Chest Syndrome
Acute Chest Syndrome
0.010 Biomarker disease BEFREE We examined a coronary artery disease predictive algorithm (CADPA) that includes 9 biomarkers involved in the pathogenesis of atherosclerosis initiated by endothelial damage and repair (hepatocyte growth factor, soluble FAS, Fas ligand, eotaxin, cutaneous T cell-attracting chemokine, monocyte chemotactic protein-3, interleukin-16, hemoglobin A1c, high-density lipoprotein-cholesterol), in addition to age, gender, diabetes, and family history of myocardial infarction that more accurately predicts 5-year risk of ACS to identify the patient population at discordantly high risk. 30563615 2019
CUI: C0948089
Disease: Acute Coronary Syndrome
Acute Coronary Syndrome
0.010 AlteredExpression disease BEFREE Analysis of apoptotic markers Fas/FasL (CD95/CD95L) expression on the lymphocytes in patients with acute coronary syndrome. 17853317 2007
CUI: C0948089
Disease: Acute Coronary Syndrome
Acute Coronary Syndrome
0.010 AlteredExpression disease LHGDN Analysis of apoptotic markers Fas/FasL (CD95/CD95L) expression on the lymphocytes in patients with acute coronary syndrome. 17853317 2007
CUI: C0343752
Disease: Acute HIV infection
Acute HIV infection
0.010 Biomarker disease BEFREE Deregulation of the CD95/CD95L system in lymphocytes from patients with primary acute HIV infection. 10770536 2000
CUI: C1868990
Disease: Acute HIV syndrome
Acute HIV syndrome
0.010 AlteredExpression disease BEFREE To analyze the role of CD95/CD95 ligand (CD95L) expression and functionality in peripheral blood lymphocytes (PBL) during primary, acute HIV syndrome (AHS) and in the subsequent period. 10770536 2000
CUI: C0275518
Disease: Acute infectious disease
Acute infectious disease
0.010 Biomarker group BEFREE Vaccination conferred strong protection against a massive intrarectal challenge with SIVmac251, as evidenced both by the reduction of viremia at the peak of acute infection (a mean of over 2 log(10) fold reduction) and by the full preservation of the CD28(+) CD95(+) memory CD4(+) T cells during the acute phase, a strong correlate of protection against pathogenesis. 19706700 2009
CUI: C0085669
Disease: Acute leukemia
Acute leukemia
0.010 Biomarker disease BEFREE Bcl-2 gene and its family genes Bax, Bcl-Xl as well as Fas/Apo-1 and their clinical significance in acute leukemia. 11245018 1998
CUI: C0242488
Disease: Acute Lung Injury
Acute Lung Injury
0.300 Biomarker disease CTD_human [Effects of dexamethasone on apoptosis and expression of Fas/FasL system in lung tissues of ALI rats]. 11778176 2000
CUI: C0023449
Disease: Acute lymphocytic leukemia
Acute lymphocytic leukemia
0.090 Biomarker disease BEFREE To investigate this phenomenon, we explored FAS transcript levels, cell-surface FAS protein expression and susceptibility to FAS-mediated apoptosis in four CTCL lines (MyLa, HH, SZ4, and SeAx), freshly isolated leukemic cells from a patient with SS, an acute lymphoblastic leukemia T-cell line (Jurkat), and JFL (a FAS-low variant of Jurkat). 18923451 2009
CUI: C0023449
Disease: Acute lymphocytic leukemia
Acute lymphocytic leukemia
0.090 GeneticVariation disease BEFREE Most of the CD95-sensitive cases were found among T lineage ALLs (38% of T lineage vs 10% of B lineage ALLs). 9264377 1997
CUI: C0023449
Disease: Acute lymphocytic leukemia
Acute lymphocytic leukemia
0.090 AlteredExpression disease BEFREE In the present study, FAS expression was examined in primary leukemic cells from infants with acute lymphoblastic leukemia (ALL). 12605660 2003
CUI: C0023449
Disease: Acute lymphocytic leukemia
Acute lymphocytic leukemia
0.090 Biomarker disease BEFREE There was a highly significant correlation in B-ALL, B-ALL/CD33<sup>+</sup> and AmbLin-AL between CD95 and Bcl-2, CD95-Active caspase-3, and Bcl-2-Active caspase-3; while in T-ALL, there was only a correlation between CD95-Active caspase-3, and Bcl-2-Active caspase-3. 29680307 2018